Poliomyelitis (polio)

    Overview

    Since 2000, the Western Pacific Region has maintained polio-free status. 

    Poliomyelitis is a highly infectious disease caused by a poliovirus. It mainly affects children under 5 years of age but also can affect older age groups. Polioviruses are spread by faecal-to-oral and oral-to-oral transmission. Lack of access to clean water and adequate sanitation is a major risk factor for transmission.

    Most infected people have no symptoms but can transmit infection to others by excreting the virus in their faeces. It is estimated that one in 200 infections leads to irreversible paralysis. Among those paralysed, 5–10% will die when their breathing muscles become immobilized. 

    There is no cure for polio; however, it can be prevented by vaccination.

    Symptoms

    Poliovirus is highly infectious. The incubation period is usually 7–10 days but can range from 4–35 days.

    The virus enters the body through the mouth and multiplies in the intestine. It then invades the nervous system. Up to 90% of those infected experience no or mild symptoms and the disease usually goes unrecognized.

    In others, initial symptoms include fever, fatigue, headache, vomiting, stiffness in the neck, and pain in the limbs. These symptoms usually last for 2–10 days and most recovery is complete in almost all cases. However, in the remaining proportion of cases the virus causes paralysis, usually of the legs, which is most often permanent. Of those paralysed, 5-10% die when their breathing muscles become immobilized.

    Prevention

    There is no cure for polio; it can only be prevented by immunization. The polio vaccine, given multiple times, can protect a child for life. If enough people in a community are immunized against polio, the virus will be deprived of susceptible hosts and will die out. High levels of vaccination coverage must be maintained to stop transmission and prevent outbreaks occurring.

    WHO is continuing to work with countries in the Region to stop the use of oral polio vaccine (OPV) and use only inactivated poliovirus vaccine (IPV) in routine immunization schedules, to prevent the emergence and circulation of vaccine-derived polioviruses in the future.

    Latest publications

    All →
    Immunization program data: regional and country profiles 2022

    This publication includes regional and national trends on vaccine-preventable disease cases and immunization coverage in the Western Pacific Region as...

    32nd Meeting of the Technical Advisory Group on Immunization and Vaccine-Preventable Diseases in the Western Pacific Region, 20-23 June 2023, Manila, Philippines/Hybrid: meeting report

    The 32nd Meeting of the Technical Advisory Group (TAG) on Immunization and Vaccine-Preventable Diseases in the World Health Organization (WHO) Western...

    Field guide for preparedness and response to diphtheria outbreaks in the Western Pacific Region

    Due to high routine vaccination coverage, overall counts of diphtheria case have significantly declined in the Western Pacific Region recently. However,...

    Regional strategic framework for vaccine-preventable diseases and immunization in the Western Pacific 2021-2030

    The WHO’s Regional Committee for the Western Pacific endorsed the Regional Strategic Framework for Vaccine-Preventable Diseases (‎VPDs)‎...

    Multimedia

    All →

    Our work

    News

    All →